Author

K. H. Kurth

Observed names: K H Kurth, K Kurth, K-H Kurth, K-H. Kurth, K. -H. Kurth, K. H. KURTH, K. Kurth, K.-H. Kurth, K.H Kurth, K.H. KURTH, K.H. Kurth, KH Kurth, KH Kurth (c), Kari Heinz Kurth, Kurth Kh, Kurth, K. H., Kurth, K, Kurth, K. H., Kurth, K.H., Kurth, KH, K‐H. KURTH

Observed institutions: European Organisation for Research and Treatment of Cancer, Utrecht University, Johannes Gutenberg University Mainz, European Association of Urology, Southmead Hospital, Slotervaartziekenhuis, Amsterdam UMC Location University of Amsterdam, Radboud University Medical Center, University Medical Center of the Johannes Gutenberg University Mainz, European Organisation for Research and Treatment of Cancer, Erasmus MC - Sophia Children’s Hospital, Spital Limmattal, Academisch Ziekenhuis Rotterdam, Vrije Universiteit Amsterdam, University of Amsterdam, Erasmus University Rotterdam

OpenAlex ID: A5111903801

A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer

1996 · A. Pawinski, R. Sylvester, et al. · The Journal of Urology · 293

Factors affecting recurrence and progression in superficial bladder tumours

1995 · K.H. Kurth, L. Denis, et al. · European Journal of Cancer · 276

Original Articles: Bladder Cancer: Intravesical Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Results of 2 European Organization for Research and Treatment of Cancer Randomized Trials With Mitomycin C and Doxorubicin Comparing Early Versus Delayed Instillations and Short-Term Versus Long-Term Treatment

1995 · Ch. Bouffioux, K.H. Kurth, et al. · The Journal of Urology · 169

Hyperbaric oxygen treatment for haemorrhagic radiation cystitis

1995 · R.F.M Bevers, K.H Kurth, et al. · The Lancet · 167

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer

2004 · R F M Bevers, K-H Kurth, et al. · British Journal of Cancer · 149

Original Articles

1995 · Ch. Bouffioux, K. H. Kurth, et al. · The Journal of Urology · 145

Treatment of Superficial Bladder Tumors: Achievements and Needs

2000 · K.H. Kurth, C. Bouffioux, et al. · European Urology · 124

Prognostic factors in bladder carcinoma: Histologic parameters and expression of a cell cycle‐related nuclear antigen (Ki‐67)

1992 · A. H. Mulder, J. C. S. P. Van Hootegem, et al. · The Journal of Pathology · 102

Ultrasound Litholapaxy of a Staghorn Calculus

1977 · K.H. Kurth, R. Hohenfellner, et al. · The Journal of Urology · 76

Treatment of Advanced Prostatic Cancer with Parenteral Cyproterone Acetate: A Phase III Randomised Trial*

1980 · G. H. JACOBI, J. E. ALTWEIN, et al. · British Journal of Urology · 75

Followup of Irradiated Prostatic Carcinoma by Aspiration Biopsy

1977 · K.H. Kurth, J.E. Altwein, et al. · The Journal of Urology · 75

Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer

1997 · E. C. de Boer, L. Somogyi, et al. · Urological Research · 74

Successful Treatment of Radiation Cystitis with Hyperbaric Oxygen

1989 · B.G. Rijkmans, D.J. Bakker, et al. · European Urology · 57

The Impact of Androgen Deprivation Therapy on Health Related Quality of Life in Asymptomatic Men with Lymph Node Positive Prostate Cancer

2003 · G. van Andel, K.H. Kurth · European Urology · 56

Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG)

1993 · T. M. de Reijke, P. C. N. Vos, et al. · Urological Research · 54

Prognostic factors in superficial bladder tumors

1992 · K. H. Kurth, L. Denis, et al. · Ghent University Academic Bibliography (Ghent University) · 53

BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines.

1998 · R F Bevers, E C de Boer, et al. · PubMed · 52

Initial diagnostic evaluation of men with lower urinary tract symptoms

1998 · Tomohiko Koyanagi, Walter Artibani, et al. · 47

Phase II trials in Ta, T1 bladder cancer. The marker tumour concept

1996 · A.P.M. Van Der Meijden, R.R. Hall, et al. · British Journal of Urology · 46

Current Methods of Assessing and Treating Carcinoma in Situ of the Bladder With or Without Involvement of the Prostatic Urethra

1995 · KH Kurth (c), PF Schellhammer (cc), et al. · International Journal of Urology · 43

Placebo Controlled Double-blind Study to Test the Efficacy of the Aromatase Inhibitor Atamestane in Patients with Benign Prostatic Hyperplasia not Requiring Operation

1995 · J.C. Gingell, H. Knonagel, et al. · The Journal of Urology · 42

BCG treatment and the importance of an inflammatory response

1992 · D. H. J. Schamhart, K. H. Kurth, et al. · Urological Research · 37

A combined analysis of EORTC/MRC randomized clinical trials for the prophylactic treatment of TaT1 bladder cancer. Eortc Genito-Urinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.

1996 · A Pawinski, R Sylvester, et al. · PubMed · 29

Mitomycin C Versus Estramustine in the Treatment of Hormone Resistant Metastatic Prostate Cancer: Thefinal Analysis of the European Organization Forresearch and Treatment of Cancer, Genitourinarygroup Prospective Randomized Phase III Study (30865)

1993 · D.W.W. Newling, S.D. Fossa, et al. · The Journal of Urology · 29

Intravesical chemotherapy and immunotherapy for superficial tumors

1998 · H Akaza, K.H Kurth, et al. · Urologic Oncology Seminars and Original Investigations · 28

Works count: 224

Citation count: 3,120

H-index: 27

I10-index: 61